Washington, DC 20006-5349
HELPLINE
Effective today, Aug. 1, the Meso Foundation’s new office location will be 1615 L Street NW, Suite 430, Washington, D.C. 20036. Our office numbers will…
This week, the Meso Foundation is happy to welcome two new members of our Washington, D.C. office staff: Michael Braeuninger and Jordan Fingerhut. Michael joins…
The Mesothelioma Applied Research Foundation (Meso Foundation) is excited to announce this week the addition of five new members to the Board of Directors: Richard…
UPDATE: This study has been completed with the full analysis of all 54 patients. Click here for full results. Earlier this month, during the most…
The Mesothelioma Applied Research Foundation (Meso Foundation) announced this week that Marjorie Zauderer, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, has been…
On Friday morning, we made our first stop on the 2018 International Symposium on Malignant Mesothelioma tour in Minneapolis, MN! Our executive director Mary Hesdoffer,…
Mesothelioma scientists and medical professionals convene at several conferences every year (one of which is our Symposium, the scientific portion of which will take place…
A new article reviewing progress and advances that occurred in 2017 in the management of pleural mesothelioma was just published in the May 2018 issue…
In 2004, over 14 years ago (!), the FDA approved the first ever (and the last so far) mesothelioma treatment drug – Alimta (pemetrexed) in…
In Part 1 of Rebecca’s story, she found herself in her doctor’s office, stunned by the diagnosis she had just received. Read Part 1 here.…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
